Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Stroke

  Free Subscription


Articles published in Int J Cardiol

Retrieve available abstracts of 109 articles:
HTML format
Text format



Single Articles


    May 2017
  1. BECATTINI C, Franco L, Agnelli G
    Risk of death in patients with major bleedings while on treatment with oral anticoagulants.
    Int J Cardiol. 2017;235:200.
    PubMed     Text format    


  2. ALEXOPOULOS D
    Delayed onset of novel P2Y12 receptor antagonists action post fibrinolysis.
    Int J Cardiol. 2017;234:131.
    PubMed     Text format    


    February 2017
  3. GUIMARAES LF, Stone GW, Caixeta A
    Reply: Delayed onset of novel P2Y12 receptor antagonists action post fibrinolysis.
    Int J Cardiol. 2017 Feb 11. pii: S0167-5273(17)30775.
    PubMed     Text format    


    January 2017
  4. VEDOVATI MC, Verdecchia P, Giustozzi M, Molini G, et al
    Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2017 Jan 19. pii: S0167-5273(16)34180.
    PubMed     Text format     Abstract available


    December 2016
  5. GUIMARAES LF, Genereux P, Silveira D, Pesaro AE, et al
    P2Y12 receptor inhibition with prasugrel and ticagrelor in STEMI patients after fibrinolytic therapy: Analysis from the SAMPA randomized trial.
    Int J Cardiol. 2016 Dec 27. pii: S0167-5273(16)34824.
    PubMed     Text format     Abstract available


    November 2016
  6. WYBRANIEC MT, Faryan M, Kusz B, Lasek-Bal A, et al
    CHA2DS2-VASC-AF2 score accurately predicts moderate-to-severe acute neurological dysfunction in the course of first ever ischaemic stroke.
    Int J Cardiol. 2016;228:286-288.
    PubMed     Text format    


  7. WONG CK
    Simplifying electrocardiographic assessment in STEMI reperfusion management: Pros and cons.
    Int J Cardiol. 2016;227:30-36.
    PubMed     Text format     Abstract available


  8. SASAI M, Iso Y, Mizukami T, Tomosugi N, et al
    Potential contribution of the hepcidin-macrophage axis to plaque vulnerability in acute myocardial infarction in human.
    Int J Cardiol. 2016;227:114-121.
    PubMed     Text format     Abstract available


  9. BECATTINI C, Franco L, Beyer-Westendorf J, Masotti L, et al
    Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33576.
    PubMed     Text format     Abstract available


  10. ZHOU X, Cao K, Kou S, Qu S, et al
    Usefulness of CHADS2 score for prognostic stratification of patients with coronary artery disease: A systematic review and meta-analysis of cohort studies.
    Int J Cardiol. 2016;228:906-911.
    PubMed     Text format     Abstract available


    October 2016
  11. NAVARESE EP, Kolodziejczak M, Winter MP, Alimohammad A, et al
    Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study.
    Int J Cardiol. 2016 Oct 29. pii: S0167-5273(16)33272.
    PubMed     Text format     Abstract available


    September 2016
  12. AKCAY M, Soylu K, Yanik A
    Acute thrombotic left main coronary artery; treatment with low dose slow infusion tPA.
    Int J Cardiol. 2016;224:265-266.
    PubMed     Text format    


  13. TAKEUCHI D, Inai K, Shinohara T, Nakanishi T, et al
    Blood coagulation abnormalities and the usefulness of D-dimer level for detecting intracardiac thrombosis in adult Fontan patients.
    Int J Cardiol. 2016;224:139-144.
    PubMed     Text format     Abstract available


    June 2016
  14. PALOMAKI A, Kiviniemi T, Mustonen P, Odei C, et al
    Mortality after stroke in patients with paroxysmal and chronic atrial fibrillation - The FibStroke study.
    Int J Cardiol. 2016 Jun 23. pii: S0167-5273(16)31117.
    PubMed     Text format     Abstract available


    May 2016
  15. TONG Y, Cai L, Zhang YW, Lin L, et al
    Role of functional polymorphisms of the IL-10 gene promoter in the risk of ischemic stroke in Chinese Uyghur population: One case-control study.
    Int J Cardiol. 2016;211:58-60.
    PubMed     Text format    


    April 2016
  16. XIE XX, Liu P, Wan FY, Lin SG, et al
    Blood pressure lowering and stroke events in type 2 diabetes: A network meta-analysis of randomized controlled trials.
    Int J Cardiol. 2016;208:141-6.
    PubMed     Text format    


    March 2016
  17. TONG Y, Huang X, Wang Z, Han S, et al
    Effects of functional genetic variants in PPARdelta encoding peroxisome proliferator-activated receptor delta on the risk of ischemic stroke in Chinese Han population.
    Int J Cardiol. 2016;207:297-9.
    PubMed     Text format    


  18. DELLBORG M, Eriksson P
    Randomized trials of closure of persistent foramen ovale (PFO) vs medical therapy for patients with cryptogenic stroke - Effect of lost-to-follow-up and withdrawal of consent.
    Int J Cardiol. 2016;207:308-9.
    PubMed     Text format    


    February 2016
  19. YIP HK, Yuen CM, Chen KH, Chai HT, et al
    Tissue plasminogen activator deficiency preserves neurological function and protects against murine acute ischemic stroke.
    Int J Cardiol. 2016;205:133-41.
    PubMed     Text format     Abstract available


  20. SEO WK, Kang SH, Jung JM, Choi JY, et al
    Novel composite score to predict atrial Fibrillation in acute stroke patients: AF predicting score in acute stroke.
    Int J Cardiol. 2016;209:184-189.
    PubMed     Text format     Abstract available


  21. MELGAARD L, Gorst-Rasmussen A, Sogaard P, Rasmussen LH, et al
    Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation.
    Int J Cardiol. 2016;209:1-6.
    PubMed     Text format     Abstract available


  22. LEE YB, Jeong SW, Rhee MY, Leem CH, et al
    Aorta-to-arm pulse wave transit time ratio: Better prediction of coronary artery disease and stroke than pulse wave velocity.
    Int J Cardiol. 2016;204:1-3.
    PubMed     Text format    


    January 2016
  23. CHHABRA L
    Importance of P-wave indices in stroke.
    Int J Cardiol. 2016;203:962-3.
    PubMed     Text format    


  24. LEE YJ, Park JK, Uhm JS, Kim JY, et al
    Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy.
    Int J Cardiol. 2016;203:372-8.
    PubMed     Text format     Abstract available


  25. KEFER J, Tzikas A, Freixa X, Shakir S, et al
    Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
    Int J Cardiol. 2016;207:335-340.
    PubMed     Text format     Abstract available


  26. PANG J, Zhang Z, Zheng TZ, Bassig BA, et al
    Green tea consumption and risk of cardiovascular and ischemic related diseases: A meta-analysis.
    Int J Cardiol. 2016;202:967-74.
    PubMed     Text format     Abstract available


  27. MAR PL, Familtsev D, Ezekowitz MD, Lakkireddy D, et al
    Periprocedural management of anticoagulation in patients taking novel oral anticoagulants: Review of the literature and recommendations for specific populations and procedures.
    Int J Cardiol. 2016;202:578-85.
    PubMed     Text format     Abstract available


    December 2015
  28. CHEN YL, Tsai TH, Wallace CG, Chen YL, et al
    Intra-carotid arterial administration of autologous peripheral blood-derived endothelial progenitor cells improves acute ischemic stroke neurological outcomes in rats.
    Int J Cardiol. 2015;201:668-83.
    PubMed     Text format     Abstract available


  29. KANAI M, Kubo H, Kitamura Y, Izawa KP, et al
    Difference in autonomic nervous activity in different subtypes of noncardioembolic ischemic stroke.
    Int J Cardiol. 2015;201:171-3.
    PubMed     Text format    


  30. GUO X, Li Z, Sun G, Guo L, et al
    Comparison of four nontraditional lipid profiles in relation to ischemic stroke among hypertensive Chinese population.
    Int J Cardiol. 2015;201:123-5.
    PubMed     Text format    


  31. TIAN L, Qiu H, Pun VC, Ho KF, et al
    Carbon monoxide and stroke: A time series study of ambient air pollution and emergency hospitalizations.
    Int J Cardiol. 2015;201:4-9.
    PubMed     Text format     Abstract available


    November 2015
  32. GARG J, Chaudhary R, Krishnamoorthy P, Shah N, et al
    Safety and efficacy of uninterrupted periprocedural rivaroxaban in patients undergoing atrial fibrillation catheter ablation: A metaanalysis of 1,362 patients.
    Int J Cardiol. 2015;203:906-908.
    PubMed     Text format    


  33. MEYER ML, Jaensch A, Mons U, Breitling LP, et al
    Atrial fibrillation and long-term prognosis of patients with stable coronary heart disease: Relevance of routine electrocardiogram.
    Int J Cardiol. 2015;203:1014-1015.
    PubMed     Text format    


  34. KONNO S, Munakata M
    High-density lipoprotein cholesterol might be a better predictor of stroke than other lipid measures in the general Japanese population: The Watari study.
    Int J Cardiol. 2015;203:874-876.
    PubMed     Text format    


  35. MARCUCCI M, Skjoth F, Lip GY, Iorio A, et al
    A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation.
    Int J Cardiol. 2015;203:785-790.
    PubMed     Text format     Abstract available


  36. YANG Y, Liu Q, Wu Z, Li X, et al
    Is hyperuricemia a recognizable biomarker for low risk of stroke in patients with atrial fibrillation?
    Int J Cardiol. 2015;203:624-625.
    PubMed     Text format    


  37. PIRINEN J, Putaala J, Aro AL, Surakka I, et al
    Resting 12-lead electrocardiogram reveals high-risk sources of cardioembolism in young adult ischemic stroke.
    Int J Cardiol. 2015;198:196-200.
    PubMed     Text format     Abstract available


    October 2015
  38. EYUBOGLU M
    Inadequate anticoagulation by Vitamin K antagonists and major adverse cardiovascular events other than stroke.
    Int J Cardiol. 2015 Oct 30. pii: S0167-5273(15)30553.
    PubMed     Text format    


  39. PALOMAKI A, Mustonen P, Hartikainen JE, Nuotio I, et al
    Strokes after cardioversion of atrial fibrillation - The FibStroke study.
    Int J Cardiol. 2015;203:269-273.
    PubMed     Text format    


  40. GARGIULO G, Capodanno D, Sannino A, Barbanti M, et al
    New-onset atrial fibrillation and increased mortality after transcatheter aortic valve implantation: A causal or spurious association?
    Int J Cardiol. 2015;203:264-266.
    PubMed     Text format    


  41. LIN YS, Tung TH, Wang J, Chen YF, et al
    Peripheral arterial disease and atrial fibrillation and risk of stroke, heart failure hospitalization and cardiovascular death: A nationwide cohort study.
    Int J Cardiol. 2015;203:204-211.
    PubMed     Text format     Abstract available


  42. PASTORI D, Pignatelli P, Saliola M, Carnevale R, et al
    Reply to: "Inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke".
    Int J Cardiol. 2015 Oct 17. pii: S0167-5273(15)30687.
    PubMed     Text format    


  43. ZHOU X, Zhang W, Lv W, Zhou Q, et al
    Left atrial appendage occlusion in atrial fibrillation for stroke prevention: A systemic review.
    Int J Cardiol. 2015;203:55-59.
    PubMed     Text format     Abstract available


  44. HUANG H, Zeng J, Kang Y, Huang H, et al
    Acute ischemia stroke: A rare and severe complication of ovarian hyperstimulation syndrome.
    Int J Cardiol. 2015;203:418-419.
    PubMed     Text format    


  45. BAIN LK, Myint PK, Jennings A, Lentjes MA, et al
    The relationship between dietary magnesium intake, stroke and its major risk factors, blood pressure and cholesterol, in the EPIC-Norfolk cohort.
    Int J Cardiol. 2015;196:108-14.
    PubMed     Text format     Abstract available


    September 2015
  46. ERGELEN M, Uyarel H, Goktekin O
    Interventional cardiologists in the treatment of acute ischemic stroke: New players in the game.
    Int J Cardiol. 2015;202:674-675.
    PubMed     Text format    


  47. KIM H, Ryu DR
    Difference in stroke incidence between Korean and Japanese patients initiating dialysis - era or ethnic effect?
    Int J Cardiol. 2015 Sep 25. pii: S0167-5273(15)30397.
    PubMed     Text format    


  48. NOZOE M, Kitamura Y, Kanai M, Kubo H, et al
    Physical activity in acute ischemic stroke patients during hospitalization.
    Int J Cardiol. 2015;202:624-626.
    PubMed     Text format    


  49. KAWADA T
    Risk of major cardiovascular events in patients with hemodialysis or peritoneal dialysis with special reference to stroke.
    Int J Cardiol. 2015 Sep 25. pii: S0167-5273(15)30302.
    PubMed     Text format    


  50. COLEMAN CI, Antz M, Ehlken B, Evers T, et al
    REal-LIfe Evidence of stroke prevention in patients with atrial Fibrillation - The RELIEF study.
    Int J Cardiol. 2015;203:882-884.
    PubMed     Text format    


  51. DURHEIM MT, Cyr DD, Lopes RD, Thomas LE, et al
    Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial.
    Int J Cardiol. 2015;202:589-594.
    PubMed     Text format     Abstract available


  52. MIRZADA N, Ladenvall P, Hansson PO, Eriksson P, et al
    Recurrent stroke in patients with patent foramen ovale: An observational prospective study of percutaneous closure of PFO versus non-closure.
    Int J Cardiol. 2015;195:293-9.
    PubMed     Text format     Abstract available


  53. KUMAR N, Venkatraman A, Garg N
    Seasonality in acute ischemic stroke related hospitalizations and case fatality rate in the United States.
    Int J Cardiol. 2015;195:134-5.
    PubMed     Text format    


  54. AHMAD Y, Nijjer S, Cook CM, El-Harasis M, et al
    A new method of applying randomised control study data to the individual patient: A novel quantitative patient-centred approach to interpreting composite end points.
    Int J Cardiol. 2015;195:216-24.
    PubMed     Text format     Abstract available


    August 2015
  55. YUAN M, Zhou HY, Xiao XL, Wang ZQ, et al
    Inflammatory bowel disease and risk of stroke: A meta-analysis of cohort studies.
    Int J Cardiol. 2015;202:106-109.
    PubMed     Text format    


  56. BLANN AD, Banerjee A, Lane DA, Torp-Pedersen C, et al
    Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study.
    Int J Cardiol. 2015;201:693-698.
    PubMed     Text format     Abstract available


  57. PASTORI D, Pignatelli P, Saliola M, Carnevale R, et al
    Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation.
    Int J Cardiol. 2015;201:513-516.
    PubMed     Text format     Abstract available


  58. PENG H, Chen M, Li G, Zhang M, et al
    Combination refusion therapy for a hemodynamically unstable patient with acute myocardial infarction complicated by acute ischemic stroke within a time window.
    Int J Cardiol. 2015;201:152-153.
    PubMed     Text format    


  59. CHENG CL, Chien HC, Lee CH, Lin SJ, et al
    Validity of in-hospital mortality data among patients with acute myocardial infarction or stroke in National Health Insurance Research Database in Taiwan.
    Int J Cardiol. 2015;201:96-101.
    PubMed     Text format     Abstract available


    July 2015
  60. BATUROVA MA, Lindgren A, Carlson J, Shubik YV, et al
    Predictors of new onset atrial fibrillation during 10-year follow-up after first-ever ischemic stroke.
    Int J Cardiol. 2015;199:248-252.
    PubMed     Text format     Abstract available


  61. XU T, Ke K
    C-reactive protein and ischemic stroke risk in general population: A dose-response meta-analysis of prospective studies.
    Int J Cardiol. 2015;190:264-7.
    PubMed     Text format    


  62. TONG Y, Lu Q, Zhang Y, Zhan F, et al
    Association of functional genetic variants in PPARgamma and PPARalpha encoding peroxisome proliferator-activated receptors with ischemic stroke in a unique Chinese population.
    Int J Cardiol. 2015;190:205-7.
    PubMed     Text format    


  63. ACAMPA M, Guideri F, Tassi R, Dello Buono D, et al
    P wave dispersion in cryptogenic stroke: A risk factor for cardioembolism?
    Int J Cardiol. 2015;190:202-4.
    PubMed     Text format    


    June 2015
  64. LAI HC, Chien WC, Chung CH, Lee WL, et al
    Atrial fibrillation, CHA2DS2-VASc score, antithrombotics and risk of traffic accidents: A population-based cohort study.
    Int J Cardiol. 2015;197:133-139.
    PubMed     Text format     Abstract available


  65. PASTORI D, Farcomeni A, Bucci T, Cangemi R, et al
    Response to "Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality".
    Int J Cardiol. 2015;189:247-8.
    PubMed     Text format    


  66. AGARWAL S, Parashar A, Kumbhani DJ, Svensson LG, et al
    Comparative meta-analysis of balloon-expandable and self-expandable valves for transcatheter aortic valve replacement.
    Int J Cardiol. 2015;197:87-97.
    PubMed     Text format     Abstract available


  67. LASEK-BAL A, Gasior Z, Kowalewska-Twardela T, Urbanek T, et al
    New-onset atrial fibrillation in patients with elevated troponin I levels in the acute phase of stroke.
    Int J Cardiol. 2015;195:210-211.
    PubMed     Text format    


    May 2015
  68. CHEN JJ, Lin LY, Yang YH, Hwang JJ, et al
    Anti-platelet or anti-coagulant agent for prevention of ischemic stroke in patients with end-stage renal disease and atrial fibrillation, is it necessary?
    Int J Cardiol. 2015;196:53.
    PubMed     Text format    


  69. BRAMBATTI M, Darius H, Oldgren J, Clemens A, et al
    Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial.
    Int J Cardiol. 2015;196:127-131.
    PubMed     Text format     Abstract available


  70. XIONG Q, Chen S, Senoo K, Proietti M, et al
    The CHADS and CHADS-VASc scores for predicting ischemic stroke among East Asian patients with atrial fibrillation: A systemic review and meta-analysis.
    Int J Cardiol. 2015;195:237-242.
    PubMed     Text format     Abstract available


  71. LOSI MA, Izzo R, Stabile E, Sannino A, et al
    Diastolic dysfunction reduces stroke volume during daily's life activities in patients with severe aortic stenosis.
    Int J Cardiol. 2015;195:64-65.
    PubMed     Text format    


  72. POTLURI R, Wasim M, Markandey B, Kapour A, et al
    Length of hospital stay is shorter in South Asian patients with ischaemic stroke.
    Int J Cardiol. 2015;187:190-1.
    PubMed     Text format    


  73. WONG K, Sze S, Wong S, McSwiggan S, et al
    Myocardial fibrosis in stroke survivors.
    Int J Cardiol. 2015;187:138-40.
    PubMed     Text format    


  74. HURLEY C, Dai S, Sobieraj DM
    The impact of inpatient rivaroxaban versus warfarin on hospital-based outcomes when used for stroke prevention in patients with anticoagulant naive, new-onset nonvalvular atrial fibrillation.
    Int J Cardiol. 2015;192:1-2.
    PubMed     Text format    


    April 2015
  75. STERLING LH, Windle SB, Filion KB, Eisenberg MJ, et al
    Pharmacological management strategies for stroke prevention following transcatheter aortic valve replacement: A systematic review.
    Int J Cardiol. 2015;191:303-311.
    PubMed     Text format     Abstract available


  76. HSU CW, Huang YB, Chen CY
    Effect of antithrombotic and antiplatelet agents for ischemic stroke in atrial fibrillation patients with dialysis.
    Int J Cardiol. 2015;190:349.
    PubMed     Text format    


  77. LI M, Li K, Zhang XW, Hou WS, et al
    Habitual snoring and risk of stroke: A meta-analysis of prospective studies.
    Int J Cardiol. 2015;185:46-9.
    PubMed     Text format    


  78. WANG J, Gu C, Gao M, Yu W, et al
    Comparison of the incidence of postoperative neurologic complications after on-pump versus off-pump coronary artery bypass grafting in high-risk patients: A meta-analysis of 11 studies.
    Int J Cardiol. 2015;185:195-7.
    PubMed     Text format    


  79. MOSCHONAS IC, Goudevenos JA, Tselepis AD
    Protease-activated receptor-1 antagonists in long-term antiplatelet therapy. Current state of evidence and future perspectives.
    Int J Cardiol. 2015;185:9-18.
    PubMed     Text format     Abstract available


  80. VAN DOORN S, Hartman-Weide F, Geersing GJ, Oudega R, et al
    Reasons for non-adherence to practice guidelines on stroke prevention in patients with atrial fibrillation: A cross-sectional study in primary care.
    Int J Cardiol. 2015;187:525-526.
    PubMed     Text format    


  81. YILDIZ A, Soydinc S
    Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality.
    Int J Cardiol. 2015;184:512-3.
    PubMed     Text format    


  82. FINSTERER J, Zarrouk-Mahjoub S
    Management of juvenile stroke from noncompaction with muscular dystrophy.
    Int J Cardiol. 2015;184:371-2.
    PubMed     Text format    


  83. LI M, Zhang Z, Chen Y
    A comparison of stroke and coronary risks in Chinese and American.
    Int J Cardiol. 2015;184:251-3.
    PubMed     Text format    


  84. ZHANG E, Liu T, Li Z, Zhao J, et al
    High CHA2DS2-VASc score predicts left atrial thrombus or spontaneous echo contrast detected by transesophageal echocardiography.
    Int J Cardiol. 2015;184:540-2.
    PubMed     Text format    


  85. CARLSSON AC, Wandell P, Gasevic D, Sundquist J, et al
    Neighborhood deprivation and warfarin, aspirin and statin prescription - A cohort study of men and women treated for atrial fibrillation in Swedish primary care.
    Int J Cardiol. 2015;187:547-552.
    PubMed     Text format     Abstract available


    March 2015
  86. RUNEV NM, Dimitrov SM
    Management of stroke prevention in Bulgarian patients with non-valvular atrial fibrillation (BUL-AF Survey).
    Int J Cardiol. 2015;187:683-685.
    PubMed     Text format    


  87. CHEN CH, Chen MC, Gibbs H, Kwon SU, et al
    Antithrombotic treatment for stroke prevention in atrial fibrillation: The Asian agenda.
    Int J Cardiol. 2015;191:244-253.
    PubMed     Text format     Abstract available


  88. NAIROOZ R, Sardar P, Pino M, Aronow WS, et al
    Meta-analysis of risk of stroke and thrombo-embolism with rivaroxaban versus vitamin K antagonists in ablation and cardioversion of atrial fibrillation.
    Int J Cardiol. 2015;187:345-353.
    PubMed     Text format     Abstract available


  89. LIN HJ, Chen ST, Wu HY, Hsu HC, et al
    Urinary biomarkers of oxidative and nitrosative stress and the risk for incident stroke: a nested case-control study from a community-based cohort.
    Int J Cardiol. 2015;183:214-20.
    PubMed     Text format     Abstract available


  90. O'NEAL WT, Tanner RM, Efird JT, Baber U, et al
    Atrial fibrillation and incident end-stage renal disease: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
    Int J Cardiol. 2015;185:219-223.
    PubMed     Text format     Abstract available


  91. DENTALI F, Botto GL, Gianni M, Ambrosino P, et al
    Efficacy and safety of direct oral anticoagulants in patients undergoing cardioversion for atrial fibrillation: A systematic review and meta-analysis of the literature.
    Int J Cardiol. 2015;185:72-77.
    PubMed     Text format     Abstract available


  92. WONG CX, Lee SW, Gan SW, Mahajan R, et al
    Underuse and overuse of anticoagulation for atrial fibrillation: A study in Indigenous and non-Indigenous Australians.
    Int J Cardiol. 2015;191:20-24.
    PubMed     Text format     Abstract available


  93. MCCALL SJ, Musgrave SD, Potter JF, Hale R, et al
    The shock index predicts acute mortality outcomes in stroke.
    Int J Cardiol. 2015;182:523-7.
    PubMed     Text format     Abstract available


  94. WANG J, Gu C, Gao M, Yu W, et al
    Adjunct coronary endarterectomy increases cerebrovascular accident after coronary artery bypass grafting: a meta-analysis of 17,600 patients.
    Int J Cardiol. 2015;182:79-81.
    PubMed     Text format    


    February 2015
  95. SZYMANSKI FM, Platek AE, Filipiak KJ
    Is obstructive sleep apnea associated with the risk of ischemic stroke in patients with atrial fibrillation?
    Int J Cardiol. 2015;184:481-482.
    PubMed     Text format    


  96. KALEMCI S, Altun I, Akin F, Biteker M, et al
    Obstructive sleep apnea and stroke risk in atrial fibrillation: Is there a correlation or not?
    Int J Cardiol. 2015;184C:306.
    PubMed     Text format    


  97. NOWAK R, Jaguszewski M, Fijalkowski M, Fijalkowska M, et al
    CMR to distinguish Takotsubo cardiomyopathy from myocardial infarction in acute course of ischemic stroke in a male patient.
    Int J Cardiol. 2015;184C:397-398.
    PubMed     Text format    


  98. SENOO K, Lane DA, Lip GY
    Stroke risk reduction with oral anticoagulation using CHA2DS2-VASc in a Japanese AF population: A modeling analysis.
    Int J Cardiol. 2015;181:247-54.
    PubMed     Text format     Abstract available


  99. KRAL M, Sanak D, Veverka T, Hutyra M, et al
    Troponin T: Correlation with location and volume of acute brain infarction.
    Int J Cardiol. 2015;181:127-32.
    PubMed     Text format     Abstract available


    January 2015
  100. RAPOSEIRAS-ROUBIN S, Garcia-Seara J, Cabanas-Grandio P, Abu-Assi E, et al
    Is safe to discontinue anticoagulation after successful ablation of atrial flutter?
    Int J Cardiol. 2015;201:631-632.
    PubMed     Text format    


  101. WINKEL P, Hilden J, Hansen JF, Kastrup J, et al
    Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10years in the CLARICOR randomised, blinded clinical trial.
    Int J Cardiol. 2015;182C:459-465.
    PubMed     Text format     Abstract available


  102. MENON J, Vijayakumar N, Joseph JK, David PC, et al
    Below the poverty line and non-communicable diseases in Kerala: The Epidemiology of Non-communicable Diseases in Rural Areas (ENDIRA) study.
    Int J Cardiol. 2015;187:519-24.
    PubMed     Text format     Abstract available


    December 2014
  103. CHANG CC, Chiu CC, Chiang CH, Huang CC, et al
    Obstructive sleep apnea and the risk of ischemic stroke in patients with atrial fibrillation.
    Int J Cardiol. 2014;181C:144-146.
    PubMed     Text format    


    November 2014
  104. LIP GY, Wang KL, Chiang CE
    Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal.
    Int J Cardiol. 2014;180C:246-254.
    PubMed     Text format     Abstract available


  105. PASTORI D, Farcomeni A, Bucci T, Cangemi R, et al
    Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation.
    Int J Cardiol. 2014;180C:1-5.
    PubMed     Text format     Abstract available


  106. YEH PS, Yang CM, Lin SH, Wang WM, et al
    Antithrombotic therapy for atrial fibrillation in patients with acute ischemic stroke or transient ischemic attack.
    Int J Cardiol. 2014;179C:288-291.
    PubMed     Text format    


  107. KORNEJ J, Lobe S, Efimova E, Husser D, et al
    NT-proBNP in "low risk" patients with atrial fibrillation.
    Int J Cardiol. 2014 Nov 6. pii: S0167-5273(14)02188.
    PubMed     Text format    


    October 2014
  108. VASSILIOU V, Rana B, Goddard M, Braganza D, et al
    Acute myocardial infarction and acute stroke: Between a rock and a hard place.
    Int J Cardiol. 2014;180C:214-215.
    PubMed     Text format    


  109. CHEN JJ, Lin LY, Yang YH, Hwang JJ, et al
    Anti-platelet or anti-coagulant agent for the prevention of ischemic stroke in patients with end-stage renal disease and atrial fibrillation-A nation-wide database analyses.
    Int J Cardiol. 2014;177:1008-1011.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: